Pear
Boston, United States · Founded 2013 · $234.0M raised
- Headquarters
- Boston, Massachusetts
- Employees
- 51–200
- Founded
- 2013
- Business Model
- B2B
- Total Funding
- $234.0M
- Last Round
- $100.0M Series DDec 2021
- Rounds
- 4
About
Pioneer in FDA-cleared prescription digital therapeutics for substance use disorder and mental health.
Summary
Pear is a Biotech company based in Boston, United States, founded in 2013. It has raised $234.0M in total across 4 rounds, most recently a $100.0M Series D round in Dec 2021. Investors include Arboretum Ventures, 5AM Ventures and SoftBank.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Dec 2021
Sign up to see all 4 rounds
Full funding history, per-round amounts, and investor participation.
Investors
.png)
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Specialty pharmaceutical company